Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study

International Journal of Epidemiology

Volumn 33, Issue 1, 2004, Pages 189-198

  Yuyun, Matthew F ^a   Khaw, Kay Tee ^a   Luben, Robert ^a   Welch, Ailsa ^a   Bingham, Sheila ^b   Day, Nicholas E ^a   Wareham, Nicholas J ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Albuminuria; Cardiovascular diseases; Mortality; Neoplasms; Risk factor

Indexed keywords

ALBUMIN; CREATININE;

CANCER;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; FATALITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; URINALYSIS;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 6344237874     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh008     Document Type: Article

References (40)

1. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ (Clin Res Ed) 1987;294:1651-54.
2. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med 1995;12:149-55.
3. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-18.
4. Deckert T, Yokoyama H, Mathiesen E et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ 1996;312:871-74.
5. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987;31:673-89.
6. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997;80:164-69.
7. Jensen JS, Feldt Rasmussen B, Strandgaard S, Schroll M, Borch Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000;35:898-903.
8. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998;16:1325-33.
9. Wagener DK, Harris T, Madans JH. Proteinuria as a biomarker: risk of subsequent morbidity and mortality. Environ Res 1994;66:160-72.
10. Grimm RH Jr, Svendsen KH, Kasiske B, Keane WF, Wahi MM. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 1997;63(Suppl.):S10-14.
11. Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med 2000;109:1-8.
12. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988;ii:530-33.
13. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vase Biol 1999;19:617-24.
14. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-26.
15. Roest M, Banga JD, Janssen WMT et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 2001;103:3057-61.
16. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovaseular mortality in general population. Circulation 2002;106:1777-82.
17. Rayner M, Petersen S. British Heart Foundation Health Promotion Research Group. European Cardiovascular Disease Statistics. University of Oxford: Department of Public Health, 2000.
18. Pedersen LM, Terslev L, Slrensen PG, Stokholm KH. Urinary albumin excretion and transcapillary escape rate of albumin in malignancies. Med Oncol 2000;17:117-22.
19. Day N, Oakes S, Luben R et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999;80(Suppl.1 ):95-103.
20. Friedewald WT Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Stamp RJ. Measurement of albumin in urine by end-point immunonephelometry. Ann Clin Biochem 1988;25:442-43.
22. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 1973;43:305-10.
23. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997;20:516-19.
24. Mogensen CE, Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346:1080-84.
25. American Diabetes Association. Clinical Practice Recommendations 2001. Diabetes Care 2001;24(Suppl.1).
26. Altman DR. Practical Statistics for Medical Research. 1 Edn. London: Chapman & Hall, 1991.
27. Mogensen CE, Vestbo E, Poulsen PL et al. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 1995;18:572-81.
28. Schultz CJ, Dalton RN, Turner C, Neil HA, Dunger DB. Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group. Diabet Med 2000;17:7-14.
29. Connell SJ, Hollis S, Tieszen KL, McMurray JR, Dornan TL. Gender and the clinical usefulness of the albumin: creatinine ratio. Diabet Med 1994;11:32-36.
30. Kesteloot H, Joossens JV. On the determinants of the creatinine clearance: a population study. J Hum Hypertens 1996;10:245-49.
31. Vora JP, Ibrahim HA, Bakris GL. Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management. J Hum Hypertens 2000;14:667-85.
32. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990;300:297-300.
33. Kirkwood BR. Essentials of Medical Statistics. 1 Edn. Oxford: Blackwell Science, 1999.
34. Ebrahim S, Harwood R. Stroke: Epidemiology, Evidence and Clinical Practice. Second Edn. Oxford: Oxford University Press, 1999.
35. Borch-Johnsen K, Feldt Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19:1992-97.
36. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 1995;91:831-37.
37. Gorgels WJ, van der Graaf Y, Hjemdahl P et al. Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands. Am J Epidemiol 1995;142:1157-64.
38. Deckert T, Feldt Rasmussen B, Borch Johnsen K, Jensen T, Kofoed Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-26.
39. Stehouwer CD, Yudkin JS, Fioretto P, Nosadini R. How heterogeneous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria. Nephrol Dial Transplant 1998;13:2751-54.
40. Jensen JS. Microalbuminuria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations. Dan Med Bull 2000;47:63-78.